ABSTRACT
Dynamic susceptibility contrast (DSC) MRI is commonly part of brain tumor imaging. For quantitative analysis, measurement of the arterial input function and tissue concentration time curve is required. Usually, a linear relationship between the MR signal changes and contrast agent concentration ([Gd]) is assumed, even though this is a known simplification. The aim of this study was to develop a realistic 3D simulation model as an efficient method to assess the relationship between ΔR 2 (*) and [Gd] both in whole blood and brain tissue. We modified an open‐source 3D simulation model to study different red blood cell configurations for assessing whole‐blood ΔR 2 (*) versus [Gd]. The results were validated against previously obtained 2D data and in vitro data. Furthermore, hematocrit levels (30%–50%) and field strengths (1.5–3.0–7.0 T) were varied. Subsequently, realistic tumor vascular networks were derived from intraoperative high framerate Doppler ultrasound data to study the influence of vascular structure and orientation with respect to the main magnetic field (1.5–3.0–7.0 T) for the calculation of ΔR 2 (*) versus [Gd] in brain tissue. For whole blood, good agreement of the 3D model was found with in vitro and 2D simulation data when red blood cells were aligned with the blood flow. For brain tissue, minor differences were found between the vascular networks. The effect of vessel direction with respect to B 0 was apparent in case of clear directionality of the main vessels. The dependency on field strength agreed with previous reports. In conclusion, we have shown that the relationship between ΔR 2 (*) and [Gd] is affected by the organization of red blood cells and orientation of blood vessels with respect to the main magnetic field, as well as the field strength. These findings are important for further optimization of the realistic 3D model that could eventually be used to improve the estimation of hemodynamic parameters from DSC‐MRI.
Keywords: arterial input function, dynamic susceptibility contrast MRI (DSC‐MRI), hematocrit dependency, magnetic field strength, oxygen saturation, simulations
Quantitative DSC perfusion MRI requires knowledge of the relationship between R 2 (*) relaxation and the concentration of contrast agent. This relationship depends on both physiological and MR parameters, as well as the structure and orientation of the vascular network with respect to the main magnetic field. Our realistic 3D model provides an efficient method to investigate this relationship, and by further optimizing the vascular segmentations, the model could eventually be used to improve the estimation of hemodynamic parameters from DSC‐MRI.
Abbreviations
- AIF
arterial input function
- CBV
cerebral blood volume
- DCE
dynamic contrast enhanced
- DSC
dynamic susceptibility contrast
- RBC
red blood cell
1. Introduction
Dynamic susceptibility contrast MRI (DSC‐MRI) is widely used for brain tumor diagnosis and follow‐up. Several studies have highlighted its role in tumor grading, treatment evaluation, and prediction of disease progression [1, 2, 3, 4, 5, 6]. In addition, DSC‐MRI has shown potential to provide relevant information related to the tumor's molecular status as derived from imaging biomarkers [7, 8, 9]. Recently, more studies have been exploring imaging biomarkers that are related to the vascular characteristics in the tumor, which can be derived by the combined use of spin‐echo and gradient‐echo sequences [10]. Combining these two techniques into what is called vessel size imaging or vascular architectural imaging has shown potential for tumor grading and characterization of the tumor's genetic status [11, 12, 13, 14, 15]. While the spin‐echo technique is more specific to the microarchitecture [16], the gradient‐echo sequence remains the preferred method to measure DSC perfusion [17].
An essential step in the quantitative analysis of DSC‐MRI data is to account for the arterial input function (AIF) that represents the delivery of contrast agent into the tissue. Deconvolution of the concentration time curve in the tissue and the AIF yields the residue function, which represents the impulse response function in the tissue after an instantaneous injection of contrast agent. Subsequently, from the residue function, hemodynamic parameters, such as cerebral blood volume (CBV, from the area under the residue function), cerebral blood flow (from the maximal value of the residue function), and mean transit time (from the ratio of CBV over CBF), are estimated. Especially the CBV is a clinically relevant hemodynamic parameter for brain tumor diagnosis and follow‐up.
The AIF and the tissue concentration time curve are generally calculated from the change in R 2* or R 2 relaxation, which is derived from the MR signal changes induced by the contrast agent, under the assumption of linearity between the changes in R 2 or R 2* relaxation and the contrast agent concentration. However, previous in vitro experiments using a gradient‐echo sequence showed evidence of a quadratic relation between R 2* and the contrast agent concentration in human whole blood [18, 19]. In addition, the blood hematocrit level and MR parameters such as sequence type (gradient echo vs. spin echo) and field strength have shown to influence this relation [20, 21, 22, 23, 24]. A strong correlation between hematocrit and R 2* has been demonstrated in vitro [25]. Recently, the influence of the hematocrit and oxygen saturation was studied by using a model that incorporates both the effects of exchange between compartments and the effects of diffusion through the local magnetic field gradients [26]. Blockley et al. [27] concluded that the field strength affected the R 1 and R 2* relaxivities in whole blood for different contrast agents. Besides, the relationship between the R 2* or R 2 relaxation and contrast agent concentration is dependent on whether the measurement is performed in arterial blood or tissue [20].
Although these in vitro experiments provided useful information, they are laborious and therefore not preferred for studying the influence of multiple hemodynamic or MR parameters. Simulations provide an alternative and more efficient approach to study the relation between R 2* or R 2 and contrast concentration. However, most simulation studies used randomly oriented infinite cylinders to model the vasculature, which does not reflect the actual structure and organization of a brain tumor's vascular network. Furthermore, DSC‐MRI simulation studies that incorporate both whole‐blood arterial and microvascular structures are limited.
In our previous work [28], we used an adapted open‐source 2D simulation tool to study the influence of hematocrit level and field strength on the relation between ΔR 2 (*) and the contrast agent concentration in whole blood (in this work, the notation ΔR 2 (*) referred to both ΔR 2* and ΔR 2, corresponding to the gradient‐echo R 2* relaxation and spin‐echo R 2 relaxation, respectively). The results showed a dependency of this relation on the red blood cell orientation with respect to the main magnetic field. However, the 2D simulation does not capture all aspects of the 3D susceptibility distribution–induced R 2 (*) changes, which indicates the need for a more realistic 3D model. Therefore, in this work, we used a 3D extension of the original 2D simulation model to represent a 3D whole‐blood voxel [29]. Additionally, we studied the relation between ΔR 2 (*) and the contrast agent concentration not only in whole blood but also in the microvasculature.
The first part of the study focused on the whole‐blood level, for which we validated the 3D simulation setup for the blood signal in a DSC acquisition by comparison with the previously measured in vitro data in whole blood for gradient‐echo sequences [19] and with our 2D simulation results. In the second part of the study, which focused on the tissue level, we incorporated realistic vascular networks of brain tumors in the simulation model, which were derived from intraoperative high framerate ultrafast Doppler ultrasound data [30]. The aim of this study was to establish a realistic 3D model to calculate the AIF and tissue concentration time curve from the R 2* relaxation, which incorporates the characteristics and structure of the vasculature, the blood hematocrit, MR sequence (gradient echo vs. spin echo), orientation of the main magnetic field, and field strength (1.5–3–7 T). The application of the established model on realistic vascular anatomies allows for a more accurate and case‐specific quantitative analysis of DSC‐MRI perfusion data.
2. Methods
2.1. Simulation Setup
The simulations were performed using a privately shared extension to 3D simulations of the MRVox software, which is publicly available on GitHub (https://github.com/nifm‐gin/MrVox2D). The simulation model consists of three blocks, where the first block includes generating or loading a (vascular) geometry. The second block models the inflow, leakage, and distribution of contrast agent in the simulation space. The third block calculates the MR signal changes, where the relaxation effects, susceptibility changes, and the diffusion of water molecules are considered. The susceptibility‐induced magnetic field changes are calculated using a Fourier‐based approach [31, 32]. The diffusion of contrast agent is modeled by a Gaussian diffusion kernel [33, 34]. Some adjustments were made for the small diffusion per time step to avoid too much discretization in sampling the Gaussian, where the diffusion kernel was adjusted such that the intended displacement at a certain point matched that of directly neighboring points. Furthermore, minor changes were made in order to speed up the simulations, for example, the real‐time plots were discarded and calculations of the contrast agent concentrations were only performed for each repetition time (TR = 1 s) instead of every timestep of the simulation (dt = 0.5 ms). Because this study entirely focusses on the T 2 changes, it was assumed that the contrast agent remained in the vasculature. Also, the r 1 relaxivity of the contrast agent was set to zero. Figure 1 provides an overview of the simulation model. Table 1 summarizes the input parameters that were used for our experiments.
TABLE 1.
Type | Parameter | Value |
---|---|---|
Lattice | Dimension | 128 × 128 × 128 voxels |
Size | 256 × 256 × 256 μm3 | |
RBCs | Radius | 1.25 and 3.5 μm for short and long axes [35] |
Magnetic susceptibility | −0.736 * 10−6 ppm cgs (assuming Y = 100%) [36] | |
T 1 | 1000 ms a | |
T 2 | Varying with field strength (200/117/50 ms for B 0 of 1.5/3/7 T) [26] | |
Proton concentration | 0.7 | |
Blood plasma | Magnetic susceptibility | −0.722 * 10−6 ppm cgs [36] |
T 1 | 1000 ms a | |
T 2 | Varying with field strength (1194/500/304 ms for B 0 of 1.5/3/7 T) [26] | |
Proton concentration | 0.95 | |
Vasculature | Magnetic susceptibility | χ vasculature = Hematocrit * (χ oxyHb + (1‐SO2) * χ Δ(de)oxyHb) + (1 − Hematocrit) * χ plasma with χ oxyHb = 4π * (−0.736 * 10−6), χ Δ(de)oxyHb = 4π * (0.264 * 10−6) (difference between fully oxygenated and deoxygenated RBCs) and χ plasma = 4π * (−0.722 * 10−6) [36] |
T 1 | 1500 ms a | |
T 2 | 70 ms | |
Contrast agent | r 1 (T 1 relaxivity) | 0 mM−1 s−1 a |
r 2 (T 2 relaxivity) | Varying with field strength (4.6/5.2/4.8 mM−1 s−1 for B 0 of 1.5/3/7 T) [37, 38] | |
Diffusivity | 48.5 * 10−11 m2 s−1 (default D free) [39] | |
Permeability | 0 s−1 | |
Magnetic susceptibility | 4π * 2.55 * 10−8 mM−1 [19] | |
MRI | TE | 20/40 ms (gradient echo/spin echo) |
TR | 1000 ms | |
Excitation time | 0 s | |
FA | 90°/90°–180° (gradient echo/spin echo) | |
Static magnetic field | Varying (1.5/3/7 T) | |
Other | Water diffusivity | 760 * 10−12 m2 s−1 (default D free) [39] |
To minimize T 1 effects to reflect complete refreshment of flowing blood.
2.2. Whole‐Blood Simulations
The original model generates a geometry consisting of blood vessels and extravascular space. In this part of the study, the geometry that originally corresponded to blood vessels was used to represent the red blood cells, while for the original extravascular space, the model parameters were changed in order to represent the blood plasma. A biconcave shape was applied for the red blood cell geometry. The contrast agent was contained within the blood plasma by simulating an impermeable red blood cell wall. Free diffusion of water was assumed [39]. Initially, the 3D simulation model was validated against the previously obtained in vitro data with a hematocrit of 36% and field strength of 1.5 T [19]. For this purpose, a linearly increasing contrast agent concentration was used with a maximum concentration of 18 mM, corresponding to a double dose of Gd [20, 40]. Subsequently, the changes in R 2* or R 2, collectively referred to as R 2 (*), were derived from the following equation:
(1) |
where S base represents the mean baseline signal magnitude after reaching equilibrium.
The T 1 effects of the contrast agent were ignored in this part of the simulations under the assumption of fresh inflow in a large artery.
Both a random and periodic distributions of red blood cells were applied. The randomly positioned cells were oriented in the same direction by default in the simulation model. In addition, randomly distributed and orientated cells were simulated by the use of the “collision‐driven molecular dynamics” algorithm [41]. This allowed for a more dense packing of cells, thus allowing for a higher maximum hematocrit level, which was previously not possible in the 2D model without causing overlap of cells. The periodic distribution included a zigzag pattern of RBCs to allow for a dense packing of cells and thus also allow for high hematocrit levels. In the next step, the influence of hematocrit level (30%–50%), field strength (1.5–3–7 T), and MR sequence (GRE vs. SE) was examined, where red blood cells with the same orientation, that is, aligned with the flow in the direction of the least resistance [42], were simulated. For the varying field strength, the experiments were repeated with the maximum contrast concentration being scaled by the field strength, that is, the maximum concentration of 18 mM was divided by the ratio of the higher field strength (3 or 7 T) and the field strength of 1.5 T, resulting in a lower maximum concentration at higher field strength.
2.3. In Vivo Dataset
Realistic tumor vascular networks of three patients with a glioma were obtained from intraoperative high framerate ultrafast Doppler ultrasound imaging as described by Soloukey et al. [30] The datasets were acquired in accordance with the local IRB regulations and after informed consent was given. Clinical characteristics are provided in Table 2, where it can be seen that the datasets contain tumor vascular networks that were derived from different tumor types. For reference, Datasets 1–3 are corresponding to Patient Numbers 3–5 in the previous work, respectively [30].
TABLE 2.
Dataset # | Sex | Age | Diagnosis | Genetic features | Blood volume fraction |
---|---|---|---|---|---|
1 | Male | 40 | Astrocytoma Grade 2 | IDH mutant | 2.6% |
2 | Male | 31 | Oligodendroglioma Grade 2 | IDH mutant, 1p/19q codeleted | 3.2% |
3 | Male | 56 | Glioblastoma | IDH wild type | 4.3% |
Postprocessing of these images and segmenting the vascular structures were performed using 3D slicer (https://www.slicer.org). This included removal of background noise by means of a Gaussian low‐pass filter and subsequent thresholding of the images with a minimum threshold of 30 dB to segment the vascular structures. Finally, smoothing segmentation tools were applied to remove connected components that consisted of less than 500 voxels. The resulting vascular segmentations were incorporated into the simulation tool.
2.4. Microvascular Simulations
The influence of vascular structure and orientation with respect to the main magnetic field was studied. In this part of the study, a first bolus passage was simulated by using the default gamma variate function included in the original simulation tool, with the following parameters: gamma variate parameter = 7000, α = 2.6, β = 0.56, dilution time = 5 s. The peak concentration of the AIF was defined as 18 mM, thus the same as for the whole‐blood experiments in the first part of the study. For the vessel orientation experiments, we started by simulating five parallel vessels with the same radius, where the B 0 direction was varied from 0° to 90° (step size of 10°). Next, a single vessel (radius = 20 μm, blood volume fraction = 1%) with an isotropic background of smaller vessels (radius = 2.5 μm, blood volume fraction = 1%) was simulated. These experiments were performed for both gradient echo and spin echo for a field strength of 1.5 T, hematocrit level of 40%, and SO2 of 60%. Subsequently, we studied the influence of main vessel orientation with respect to the B 0 field for the datasets described in Table 2. The angle between the main vessels of each dataset and the B 0 field was varied from 0° to 45° to 90°. This was achieved by varying the direction of B 0 with respect to the main vessel direction in each of the datasets, while keeping the datasets unchanged. We focused on the gradient‐echo sequence and thus ΔR 2* for these experiments, because the parameter of interest was the vessel orientation rather than MR sequence in this case. To study the different vascular structures, the three datasets described in Table 2 were compared with each other and with a random vascular network that was generated with the original simulation model. Because the ultrasound technique provided details down to submillimeter resolution, the blood vessels at the smaller capillary level needed to be added to the existing vascular networks to reach a blood volume fraction of 6% for all networks. The additional capillaries were simulated as randomly oriented cylinders with a radius of 2.5 μm. The comparison between the ultrasound derived network and the random vascular networks was performed both with and without the additional capillaries, where for each comparison the blood volume fraction of the random network matched that of the tumor vascular network. Additionally, for one of the tumor vascular networks, the simulations were repeated for varying field strength (1.5–3–7 T) and for both GRE and SE sequences. The experiments for varying field strength were performed with the same maximum concentrations and with the maximum concentration scaled according to the field strength, where the maximum concentration was lower at a higher field strength. For the microvascular experiments, the [CA] concentration corresponds to the concentration in the tissue, thus the averaged concentration over the simulation voxel.
3. Results
3.1. Whole Blood
Figure 2 shows the relationship between ΔR 2* and [Gd] in whole blood, where the 3D simulations agreed quite well with the in vitro data and previous 2D experiment, though only when red blood cells have the same orientation (red and green datapoints in Figure 2). The results for randomly oriented red blood cells show larger differences with the in vitro data. This is in agreement with previous literature mentioning the alignment of cells with the blood flow in the direction of the least resistance [42].
The hematocrit and field strength dependency are shown in Figure 3. Figure 3A,B shows a nonlinear relationship across the different hematocrit values at a field strength of 1.5 T, where the relaxivity increases with hematocrit level as expected. For the gradient‐echo sequence at the highest hematocrit level of 50%, the ΔR 2* versus [CA] curve levels off. In Figure 3C,D, the contrast agent concentration was scaled to the field strength by using a higher concentration at lower field strength. To help visualization and allow for comparison of the shape of the curves, the results are plotted against the same concentration axis for each field strength. In these figures, the field strength seems to only minimally affect the relation between ΔR 2* and [Gd], though the scaled curve for 1.5 T displays the highest relaxivity.
3.2. Microvasculature
The effect of varying the vessel orientation with respect to the B 0 field is shown in Figure 4. For five parallel vessels with the same radius (Figure 4), the effect is clear for both gradient echo and spin echo. As expected from theory, the peak ΔR 2 (*) is highest for 90°, because the extravascular field inhomogeneities are most pronounced for a vessel oriented perpendicular to the main magnetic field. Similar results were found for the single vessel with an isotropic background consisting of smaller vessels, although the datapoints for varying angles are closer together.
Next, the dependency on the orientation of the B 0 field with respect to the main blood vessels of the tumor networks was studied for a gradient‐echo sequence (Figure 5). In two of the tumor vascular networks, the highest relaxivity was seen for those cases where the main magnetic field was perpendicular to the main blood vessels, as expected from theory. For Dataset 1, the network with a BVF of 2.6% (Figure 5A), this effect was most pronounced, whereas for Dataset 2 with a BVF of 3.2% (Figure 5B), the datapoints for different angles between B 0 and the main vessels were closer together.
Figure 6 shows the relation between ΔR 2* versus [Gd] for the different tumor vascular networks in comparison with a random vascular network. In Figure 6A, the results are shown for the tumor vascular networks with additional capillaries, where it can be seen that the results for the different tumor vascular networks agreed fairly well with the random network with a blood volume fraction of 6%. The obtained relaxivity values from linear fitting were between 0.042 and 0.047 (ms * mM)−1 for the tumor vascular networks with additional capillaries compared to 0.043 (ms * mM)−1 for the random vascular network. Figure 6B–D shows the results for the tumor vascular networks without the capillaries, compared with random vascular networks with matching blood volume fractions. These results show a more pronounced difference between the random networks and the tumor vascular networks. The fitted relaxivity for Dataset 1 (Figure 6B) was 0.038 versus 0.044 (ms * mM)−1 for the random versus tumor vascular network. For Dataset 2 (Figure 6C), this was 0.039 versus 0.052 (ms * mM)−1, and for Dataset 3 (Figure 6D), this was 0.039 versus 0.047 (ms * mM)−1.
In Figure 7, the influence of sequence type (gradient echo vs. spin echo) and field strength (1.5–3–7 T) is summarized. As expected, the relaxivity is lower for the spin‐echo sequence. A higher field strength seems to increase the dephasing effects; however, when the concentration is scaled with the field strength, this effect becomes less apparent. Note that the concentration on the x axis is the same for all field strengths also for the scaled curves, which is to help visualization and to allow for direct comparison of the shape of the curves. Interestingly, the linearity of the relation decreases with the field strength, which is mainly visible for the unscaled curves in Figure 7A,C. For the gradient‐echo sequence, the fitted relaxivity values are 0.046, 0.096/0.084, and 0.24/0.25 (ms * mM)−1 s−1 at 1.5, 3.0, and 7.0 T for the unscaled/scaled concentration, respectively. For spin echo, the fitted relaxivities are 0.017, 0.043/0.042, and 0.079/0.10 (ms * mM)−1 at 1.5, 3.0, and 7.0 T for the unscaled/scaled concentration, respectively.
4. Discussion
This study was aimed to develop a realistic 3D simulation model for estimating the relationship between ΔR 2 (*) and [Gd] in whole blood and brain tumor tissue, which incorporates the dependency on blood hematocrit, vascular geometry, MR sequence type, orientation of the main magnetic field, and field strength.
In whole blood, the relationship between gradient‐echo ΔR 2* and [Gd] agreed well with the in vitro data that was obtained in previous work [19], as well as with the 2D simulation results obtained before [28]. However, this was only the case for red blood cells aligned with the blood flow, where the vessel was assumed to be oriented parallel to the main magnetic field. This agrees to the setup of the in vitro experiment, where the tube with blood was oriented parallel to the main magnetic field. For a random orientation of red blood cells, the overlap of cells could not be entirely avoided, resulting in different shape and size of the objects that are the source of dephasing effects. This overlapping of cells originates from the suboptimal incorporation of the PackLSD algorithm into the MATLAB simulation model. These differences in shape and size depending on the RBC orientation could explain the observed increase in ΔR 2* for a random RBC distribution and orientation compared to the homogeneous distribution. The in vitro data seem to lie in between the random and homogeneous distribution of the red blood cells, which might indicate some random aspect in the red blood cell distribution, though not in their orientation. This agrees with previous literature [42], which states that the red blood cells are oriented along the blood flow in a blood vessel where the flow is high, which holds true for a larger artery such as the internal carotid artery and in the in vitro setup. Therefore, our model assumption for the geometry of the red blood cells seems valid. The relaxivity increased with hematocrit as expected, and, except for a hematocrit level of 50%, a quadratic dependency was found. For the gradient‐echo sequence at the highest hematocrit level of 50%, the ΔR 2* versus [CA] curve leveled off, which could be explained by the simulation model running into digitization noise errors. We observed that the average signal at the highest concentration was only 0.04% of the precontrast baseline signal, mainly due to increased phase dispersion in the simulation volume. The increasing relaxivity with hematocrit agrees to the results of Akbudak et al. [18], where a blood phantom was used to study the dependency on hematocrit in whole blood. In general, when comparing the ΔR 2* values for the same concentration and for hematocrit levels of 30% and 40% at 1.5 T, our values are around 10%–20% higher than found previously. This could be explained by the differences between our simulations and the in vitro setup, because the simulation model lacks the effects of real blood flow (e.g., flow profile) on the behavior of the red blood cells. In contrast to our 2D simulation results, we found a quadratic shape of the ΔR 2 (*) curves even at higher field strengths, which is in accordance with previous studies [18, 20, 27]. These findings have important implications for clinical practice, because the linear assumption for AIF calculation would introduce errors in the estimation of the hemodynamic parameters. Previously, Calamante et al. [43] showed that the assumption of linearity results in errors in the CBF calculation of more than 50%. Therefore, including the quadratic dependency and accounting for the physiological and MR parameters that are discussed in our study are expected to largely improve the estimation of hemodynamic parameters from the DSC‐MRI data.
At the tissue level, we observed that the ultrasound derived real vascular networks are less strictly oriented than the random cylinders and the different datasets show clear differences in vascular organization and orientation depending on the tumor type. For the ΔR 2* curves, we found some surprising results with respect to the dependency on vessel geometry. Previous work of Hernández‐Torres et al. [44] showed a significant influence of vessel orientation, which was confirmed by us through simulation of five parallel blood vessels with varying orientation with respect to B 0 and when one large vessel was surrounded by randomly oriented capillaries (Figure 4). However, our main results showing the gradient‐echo ΔR 2* versus [Gd] for the different ultrasound networks showed less pronounced effects (Figure 6). This might be explained by the limitations of the imaging and the segmentation of the vasculature, which are not perfect, that is, there are some structures remaining that might not correspond to vessels and the shape of the vessels seems not perfectly reflected in the segmentations.
When studying the influence of the main vessel orientation with respect to the main magnetic field for the different ultrasound datasets (Figure 5), we found the most pronounced differences for Dataset 1, which is the vascular network with a BVF of 2.6%. This network (as highlighted by the blue box in Figure 6) is characterized by a clear parallel directionality of the main blood vessels surrounded by smaller vessels of which quite some have a similar direction. For Dataset 3, which is the network with a BVF of 3.2% (red box in Figure 6), the vasculature seems more tortuous and almost randomly oriented, which could explain the similar relaxivities for the parallel and perpendicular orientation of the vascular network. In comparison to the previous work of Kjølby et al. [20], where they reported relaxivity values in gray matter of 0.044 and 0.087 (ms * mM)−1 at 1.5 and 3 T, our results show reasonable agreement for the observed curves and fitted relaxivity values at 1.5 and 3.0 T of 0.046 and 0.096 (ms * mM)−1, respectively (Figure 7).
The results of this study show the potential of using a 3D simulation tool for assessing the relationship between ΔR 2* and [Gd] and is an important addition to the existing literature by incorporating realistic tumor vascular networks.
This study also has some limitations, which are related to the simulation model that could be optimized even further. The first limitation considers the T 1 changes that follow due to the presence and leakage of contrast agent, which are not included in the current model. On the whole‐blood level, the r 1 relaxivity of the contrast agent was set to zero, because in a large blood vessel, we can assume complete refreshment of flowing blood and thus neglect T 1 effects. For the tissue level, this assumption does not hold true, but we still discarded the T 1 effects and especially assumed that all contrast agent remained intravascular, in order to focus on ΔR 2*. Although both T 1 and T 2 changes are important processes that should be considered both for clinical practice, studying them independently before looking at the combined processes is required for better understanding. A next limitation is related to the size of the simulation voxel that is used, which for the whole‐blood experiments only represents a small volume within the artery where the AIF would be measured. However, increasing the simulation volume significantly increases the calculation time and memory that is needed for running the simulations, which is undesirable. The current calculation time for a single experiment is around 8 h with a memory usage of 3 GB. Also, this study focuses entirely on the amplitude of the MRI signal, whereas a phase‐based AIF is known to provide more accurate results and is less affected by the hematocrit level. Contrast agent–induced phase changes depend more on the large‐scale shape and orientation of vessels, which can accurately be modeled or described by analytical formulas when assuming infinite cylindrical shapes [45]. Bridging the small‐ and large‐scale models could in principle be performed by similar simulations as we applied in this study but would be too computational expensive in practice. Moreover, phase‐based AIF measurements have never really been adopted in clinical examinations. Another limitation is related to the flattening off for the ΔR 2* curves at higher concentrations for random distribution and orientation of red blood cells (Figure 2), also seen at higher hematocrit levels for the whole‐blood experiments (Figure 3) and field strength for the microvascular experiments (Figure 7). This behavior seems to originate from discretization noise of the simulation model, because a higher resolution seems to avoid this behavior at high concentrations (see Figure S1).
For the tissue level simulations, the oxygenation was kept the same throughout the vascular networks, although this varies depending on vessel type; thus, it influences the relaxivity in the simulation voxel. Furthermore, oxygenation is also influenced by tumor type and could even vary within the tumor region. However, as the oxygen distribution is independent of the contrast concentration and can be assumed constant in time, including this in our model would only cause a general shift in the data and does not substantially change the ΔR 2 (*) values. Another limitation is that the ultrasound data lacks capillary information, because the probe was not sensitive enough to detect the smallest parts of the vascular network. In this study, we added capillaries to the existing vascular networks to attempt making the model more realistic, although this means that any directionality of the capillaries is not accounted for. The structure and directionality of the capillary bed could potentially affect the relationship between ΔR 2* and [Gd], as indicated by the strong dependency on vascular orientation with respect to the main magnetic field in Figures 4 and 5. Future work should therefore focus on optimizing the vascular network segmentations, where the capillary structure and organization should better reflect the realistic scenario. A proof‐of‐concept study already developed a framework for registered ultrasound and fMRI data, which could add information about the location of the vascular structures [46].
5. Conclusions
This study shows the development towards a realistic 3D simulation model for calculating the relation between the R 2 (*) relaxation and [Gd] in whole blood and brain tumor tissue by studying the influence of vascular structure, orientation of the vascular bed with respect to the B 0 field, field strength, and sequence type. At the tissue level, incorporation of realistic vascular networks could allow for a more patient‐specific and accurate determination of the relationship between ΔR 2 (*) and [Gd]. The segmented vascular structures could be improved in further research to better reflect the capillary information of a realistic vascular network. Future work will also include acquiring preoperative MRI data in the same patients and register the ultrasound derived vascular structures to the MRI, thereby providing information about the location of the vascular structures within the tumor. To conclude, the relaxation seems to be affected by the orientation and structure of the tumor's vascular network, which could explain some of the blood volume changes that are observed in clinical practice.
Supporting information
Acknowledgments
This publication is part of the project “Vascular Signature Mapping of Brain Tumor Genotypes” (with Project Number 17079) of the open technology research program of Applied and Engineering Sciences which is (partly) financed by the Dutch Research Council (NWO) and the Medical Delta program “Cancer Diagnostics 3.0.”
Funding: This publication is part of the project “Vascular Signature Mapping of Brain Tumor Genotypes” (with Project Number 17079) of the open technology research program of Applied and Engineering Sciences which is (partly) financed by the Dutch Research Council (NWO) and the Medical Delta program “Cancer Diagnostics 3.0.”
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
- 1. Law M., Young R., Babb J., Pollack E., and Johnson G., “Histogram Analysis Versus Region of Interest Analysis of Dynamic Susceptibility Contrast Perfusion MR Imaging Data in the Grading of Cerebral Gliomas,” American Journal of Neuroradiology 28, no. 4 (2007): 761–766. [PMC free article] [PubMed] [Google Scholar]
- 2. Emblem K. E., Nedregaard B., Nome T., et al., “Glioma Grading by Using Histogram Analysis of Blood Volume Heterogeneity From MR‐Derived Cerebral Blood Volume Maps,” Radiology 247, no. 3 (2008): 808–817, 10.1148/radiol.2473070571. [DOI] [PubMed] [Google Scholar]
- 3. Aprile I., Giovannelli G., Fiaschini P., Muti M., Kouleridou A., and Caputo N., “High‐ and Low‐Grade Glioma Differentiation: The Role of Percentage Signal Recovery Evaluation in MR Dynamic Susceptibility Contrast Imaging,” Radiologia Medica 120, no. 10 (2015): 967–974, 10.1007/s11547-015-0511-7. [DOI] [PubMed] [Google Scholar]
- 4. Boxerman J. L., Schmainda K. M., and Weisskoff R. M., “Relative Cerebral Blood Volume Maps Corrected for Contrast Agent Extravasation Significantly Correlate With Glioma Tumor Grade, Whereas Uncorrected Maps Do Not,” American Journal of Neuroradiology 27, no. 4 (2006): 859–867, https://pubmed.ncbi.nlm.nih.gov/16611779/. [PMC free article] [PubMed] [Google Scholar]
- 5. Baek H. J., Kim H. S., Kim N., Choi Y. J., and Kim Y. J., “Percent Change of Perfusion Skewness and Kurtosis: A Potential Imaging Biomarker for Early Treatment Response in Patients With Newly Diagnosed Glioblastomas,” Radiology 264, no. 3 (2012): 834–843, 10.1148/radiol.12112120. [DOI] [PubMed] [Google Scholar]
- 6. Manning P., Daghighi S., Rajaratnam M. K., et al., “Differentiation of Progressive Disease From Pseudoprogression Using 3D PCASL and DSC Perfusion MRI in Patients With Glioblastoma,” Journal of Neuro‐Oncology 147, no. 3 (2020): 681–690, 10.1007/s11060-020-03475-y. [DOI] [PubMed] [Google Scholar]
- 7. Jenkinson M. D., Du Plessis D. G., Smith T. S., Joyce K. A., Warnke P. C., and Walker C., “Histological Growth Patterns and Genotype in Oligodendroglial Tumours: Correlation With MRI Features,” Brain 129, no. 7 (2006): 1884–1891, 10.1093/BRAIN/AWL108. [DOI] [PubMed] [Google Scholar]
- 8. Kickingereder P., Sahm F., Radbruch A., et al., “IDH Mutation Status Is Associated With a Distinct Hypoxia/Angiogenesis Transcriptome Signature Which Is Non‐Invasively Predictable With rCBV Imaging in Human Glioma,” Scientific Reports 5 (2015): 16238, 10.1038/SREP16238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Siakallis L., Topriceanu C. C., Panovska‐Griffiths J., and Bisdas S., “The Role of DSC MR Perfusion in Predicting IDH Mutation and 1p19q Codeletion Status in Gliomas: Meta‐Analysis and Technical Considerations,” Neuroradiology 65, no. 7 (2023): 1111–1126, 10.1007/S00234-023-03154-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Schmiedeskamp H., Straka M., Newbould R. D., et al., “Combined Spin‐ and Gradient‐Echo Perfusion‐Weighted Imaging,” Magnetic Resonance in Medicine 68, no. 1 (2012): 30–40, 10.1002/mrm.23195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Kiselev V. G., Strecker R., Ziyeh S., Speck O., and Hennig J., “Vessel Size Imaging in Humans,” Magnetic Resonance in Medicine 53, no. 3 (2005): 553–563, 10.1002/mrm.20383. [DOI] [PubMed] [Google Scholar]
- 12. Emblem K. E., Mouridsen K., Bjornerud A., et al., “Vessel Architectural Imaging Identifies Cancer Patient Responders to Anti‐Angiogenic Therapy,” Nature Medicine 19, no. 9 (2013): 1178–1183, 10.1038/nm.3289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Chakhoyan A., Yao J., Leu K., et al., “Validation of Vessel Size Imaging (VSI) in High‐Grade Human Gliomas Using Magnetic Resonance Imaging, Image‐Guided Biopsies, and Quantitative Immunohistochemistry,” Scientific Reports 9, no. 1 (2019): 2846, 10.1038/s41598-018-37564-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Arzanforoosh F., van der Voort S. R., Incekara F., et al., “Microvasculature Features Derived From Hybrid EPI MRI in Non‐Enhancing Adult‐Type Diffuse Glioma Subtypes,” Cancers (Basel) 15, no. 7 (2023): 2135, 10.3390/CANCERS15072135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Stadlbauer A., Zimmermann M., Kitzwögerer M., et al., “MR Imaging‐Derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas,” Radiology 283, no. 3 (2017): 799–809, 10.1148/radiol.2016161422. [DOI] [PubMed] [Google Scholar]
- 16. Boxerman J. L., Hamberg L. M., Rosen B. R., and Weisskoff R. M., “MR Contrast due to Intravascular Magnetic Susceptibility Perturbations,” Magnetic Resonance in Medicine 34, no. 4 (1995): 555–566, 10.1002/mrm.1910340412. [DOI] [PubMed] [Google Scholar]
- 17. Boxerman J. L., Quarles C. C., Hu L. S., et al., “Consensus Recommendations for a Dynamic Susceptibility Contrast MRI Protocol for Use in High‐Grade Gliomas,” Neuro‐Oncology 22, no. 9 (2020): 1262–1275, 10.1093/neuonc/noaa141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Akbudak E., Kotys M. S., Memisevic D., and Conturo T. E., “Quadraticity and Hematocrit Dependence of ΔR2* AIF Signals at 3 T: A Blood Phantom Study Under Physiological Conditions,” in Syllabus ISMRM Work Quant Cereb Perfus Imaging Using MRI: A Tech Perspect, (Venice, 2004): 10–11. [Google Scholar]
- 19. van Osch M. J., Vonken E. J., Viergever M. A., van der Grond J., and Bakker C. J., “Measuring the Arterial Input Function With Gradient Echo Sequences,” Magnetic Resonance in Medicine 49, no. 6 (2003): 1067–1076, 10.1002/mrm.10461. [DOI] [PubMed] [Google Scholar]
- 20. Kjølby B. F., Østergaard L., and Kiselev V. G., “Theoretical Model of Intravascular Paramagnetic Tracers Effect on Tissue Relaxation,” Magnetic Resonance in Medicine 56, no. 1 (2006): 187–197, 10.1002/mrm.20920. [DOI] [PubMed] [Google Scholar]
- 21. Bush A., Borzage M., Detterich J., et al., “Empirical Model of Human Blood Transverse Relaxation at 3 T Improves MRI T2 Oximetry,” Magnetic Resonance in Medicine 77, no. 6 (2017): 2364–2371, 10.1002/mrm.26311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Christiansen S. D., Liu J., Boffa M. B., and Drangova M., “Simultaneous R2*and Quantitative Susceptibility Mapping Measurement Enables Differentiation of Thrombus Hematocrit and Age: An In Vitro Study at 3 T,” Journal of NeuroInterventional Surgery 11, no. 11 (2019): 1155–1161, 10.1136/neurintsurg-2019-014802. [DOI] [PubMed] [Google Scholar]
- 23. Wilson G. J., Springer C. S., Bastawrous S., and Maki J. H., “Human Whole Blood 1H2O Transverse Relaxation With Gadolinium‐Based Contrast Reagents: Magnetic Susceptibility and Transmembrane Water Exchange,” Magnetic Resonance in Medicine 77, no. 5 (2017): 2015–2027, 10.1002/mrm.26284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Thulborn K. R., Waterton J. C., Matthews P. M., and Radda G. K., “Oxygenation Dependence of the Transverse Relaxation Time of Water Protons in Whole Blood at High Field,” Biochimica et Biophysica Acta, Reviews on Cancer 714, no. 2 (1982): 265–270, 10.1016/0304-4165(82)90333-6. [DOI] [PubMed] [Google Scholar]
- 25. Walsh A. J., Sun H., Emery D. J., and Wilman A. H., “Hematocrit Measurement With R2* and Quantitative Susceptibility Mapping in Postmortem Brain,” American Journal of Neuroradiology 39, no. 7 (2018): 1260–1266, 10.3174/ajnr.A5677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Li W. and van Zijl P. C. M., “Quantitative Theory for the Transverse Relaxation Time of Blood Water,” NMR in Biomedicine 33, no. 5 (2020): e4207, 10.1002/nbm.4207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Blockley N. P., Jiang L., Gardener A. G., Ludman C. N., Francis S. T., and Gowland P. A., “Field Strength Dependence of R1 and R2* Relaxivities of Human Whole Blood to ProHance, Vasovist, and Deoxyhemoglobin,” Magnetic Resonance in Medicine 60, no. 6 (2008): 1313–1320, 10.1002/mrm.21792. [DOI] [PubMed] [Google Scholar]
- 28. van Dorth D., Venugopal K., Poot D. H. J., et al., “Dependency of R2 and R2* Relaxation on Gd‐DTPA Concentration in Arterial Blood: Influence of Hematocrit and Magnetic Field Strength,” NMR in Biomedicine 35, no. 5 (2022): e4653, 10.1002/NBM.4653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Delphin A., Boux F., Brossard C., et al., “Using 3D Realistic Blood Vessel Structures and Machine Learning for MR Vascular Fingerprinting,” in Joint Annual Meeting ISMRM‐ESMRMB & ISMRT 31st Annual Meeting, London, (2022). [Google Scholar]
- 30. Soloukey S., Vincent A. J. P. E., Satoer D. D., et al., “Functional Ultrasound (fUS) During Awake Brain Surgery: The Clinical Potential of Intra‐Operative Functional and Vascular Brain Mapping,” Frontiers in Neuroscience 13 (2020): 1384, 10.3389/fnins.2019.01384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Salomir R., De Senneville B. D., and Moonen C. T. W., “A Fast Calculation Method for Magnetic Field Inhomogeneity due to an Arbitrary Distribution of Bulk Susceptibility,” Concepts in Magnetic Resonance Part B: Magnetic Resonance Engineering 19B, no. 1 (2003): 26–34, 10.1002/cmr.b.10083. [DOI] [Google Scholar]
- 32. Marques J. P. and Bowtell R., “Application of a Fourier‐Based Method for Rapid Calculation of Field Inhomogeneity due to Spatial Variation of Magnetic Susceptibility,” Concepts in Magnetic Resonance Part B: Magnetic Resonance Engineering 25B, no. 1 (2005): 65–78, 10.1002/cmr.b.20034. [DOI] [Google Scholar]
- 33. Bandettini P. and Wong E., “Effects of Biophysical and Physiologic Parameters on Brain Activation‐Induced R 2* and R 2 Changes: Simulations Using a Deterministic Diffusion Model,” International Journal of Imaging Systems and Technology 6 (1995): 133–152. [Google Scholar]
- 34. Martyn L. and Menon R. S., “NMR Simulation Analysis of Statistical Effects on Quantifying Cerebrovascular Parameters,” Biophysical Journal 92, no. 3 (2007): 1014–1021, 10.1529/BIOPHYSJ.106.087965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Kinnunen M., Kauppila A., Karmenyan A., and Myllylä R., “Effect of the Size and Shape of a Red Blood Cell on Elastic Light Scattering Properties at the Single‐Cell Level,” Biomedical Optics Express 2, no. 7 (2011): 1803–1814, 10.1364/BOE.2.001803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Spees W. M., Yablonskiy D. A., Oswood M. C., and Ackerman J. J. H., “Water Proton MR Properties of Human Blood at 1.5 Tesla: Magnetic Susceptibility, T 1, T 2, T 2*, and Non‐Lorentzian Signal Behavior,” Magnetic Resonance in Medicine 45, no. 4 (2001): 533–542, 10.1002/mrm.1072. [DOI] [PubMed] [Google Scholar]
- 37. Rohrer M., Bauer H., Mintorovitch J., Requardt M., and Weinmann H. J., “Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths,” Investigative Radiology 40, no. 11 (2005): 715–724, 10.1097/01.rli.0000184756.66360.d3. [DOI] [PubMed] [Google Scholar]
- 38. Vignaud A., Violas X., Rahmouni A., Robert P., and Amadon A., “Comparison of Marketed Gadolinium‐Based Contrast Agents Relaxivities on Clinical MR Scanner at 1.5T, 3T and 7T in Water and Plasma for a Large Range of Physiological Concentrations,” in Proceedings of the International Society for Magnetic Resonance in Medicine, vol. 54, (Stockholm, Sweden, 2010). [Google Scholar]
- 39. Pannetier N. A., Debacker C. S., Mauconduit F., Christen T., and Barbier E. L., “A Simulation Tool for Dynamic Contrast Enhanced MRI,” PLoS ONE 8, no. 3 (2013): e57636, 10.1371/journal.pone.0057636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Albert M. S., Haung W., Lee J.‐H., Patlak C. S., and Springer C. S., “Susceptibility Changes Following Bolus Injections,” Magnetic Resonance in Medicine 29, no. 5 (1993): 700–708, 10.1002/mrm.1910290520. [DOI] [PubMed] [Google Scholar]
- 41. Donev A., Torquato S., and Stillinger F. H., “Neighbor List Collision‐Driven Molecular Dynamics Simulation for Nonspherical Particles. I. Algorithmic Details II. Applications to Ellipses and Ellipsoids,” (2004), https://arxiv.org/abs/physics/0405089v1.
- 42. Cho Y.‐I. and Cho D. J., “Hemorheology and Microvascular Disorders,” Korean Circulation Journal 41, no. 6 (2011): 287–295, 10.4070/kcj.2011.41.6.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Calamante F., Connelly A., and van Osch M. J. P., “Nonlinear ΔR2* Effects in Perfusion Quantification Using Bolus‐Tracking MRI,” Magnetic Resonance in Medicine 61, no. 2 (2009): 486–492, 10.1002/mrm.21839. [DOI] [PubMed] [Google Scholar]
- 44. Hernández‐Torres E., Kassner N., Forkert N. D., et al., “Anisotropic Cerebral Vascular Architecture Causes Orientation Dependency in Cerebral Blood Flow and Volume Measured With Dynamic Susceptibility Contrast Magnetic Resonance Imaging,” Journal of Cerebral Blood Flow and Metabolism 37, no. 3 (2017): 1108–1119, 10.1177/0271678X16653134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Kiselev V. G. and Posse S., “Analytical Model of Susceptibility‐Induced MR Signal Dephasing: Effect of Diffusion in a Microvascular Network,” Magnetic Resonance in Medicine 41, no. 3 (1999): 499–509, . [DOI] [PubMed] [Google Scholar]
- 46. Soloukey S., Collée E., Verhoef L., et al., “Human Brain Mapping Using Co‐Registered fUS, fMRI and ESM During Awake Brain Surgeries: A Proof‐of‐Concept Study,” NeuroImage 283 (2023): 120435, 10.1016/J.NEUROIMAGE.2023.120435. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.